Skip to Main Content

Paper Details

Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen.
Breast Cancer Res Treat
7
2022
HRLs, High-risk lesions, aromatase, breast cancer, breast lesions, raloxifene, tamoxifen, women
Author NameAffiliation
Lydia E PaceHarvard Medical School
Lydia E PaceBrigham and Women's Hospital
Judy E GarberHarvard Medical School
Judy E GarberDana-Farber/Brigham and Women's Cancer Center
Judy E GarberDana-Farber Cancer Institute
Tari A KingHarvard Medical School
Tari A KingDana-Farber/Brigham and Women's Cancer Center
Tari A KingBrigham and Women's Hospital
  • 1 - 8

Datasets

Release 1.2